- Details
- Description
Packaging Size:
30’s
Strength:
100 mg
Composition:
Enasidenib 100 mg
Treatment:
Anti-cancer medicine used for certain cases of acute myeloid leukemia (AML) with specific IDH2 mutations, under medical supervision.
Form:
Tablet
Brand:
Enacitib
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
Enacitib 100 contains Enasidenib 100 mg, a targeted anti-cancer medicine used for certain patients with acute myeloid leukemia (AML) associated with specific IDH2 mutations. It works by inhibiting the abnormal IDH2 enzyme, helping to control the growth of cancer cells. Enacitib 100 is a prescription medicine intended for use under medical supervision.
